Neuralieve
Sunnyvale, US · Founded 2012 · Delaware corporation · 11 employees on LinkedIn · 1 known investors
eNeura develops single-pulse transcranial magnetic stimulation (sTMS) neuromodulation devices for the acute and preventive treatment of migraine. Its products are used by patients, including veterans through the VA, and prescribed by healthcare providers, with operations in the US and UK.
Founders & leadership
Neuralieve was founded in 2012 by Robert Fischell.
RF
Robert FischellFounder
DF
David FischellExecutive
DR
David RosenExecutive
Board
MF
Michael FinneganBoard director
TL
Terry LiermanBoard director
EO
Eileen O'RourkeBoard director
WK
William KirwanBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$48.6M disclosed across 9 rounds · 2013–2020
▶$511KraisedFeb 2020 · 39 investors · Other TechnologyRule 506(b)
▶$511KraisedFeb 2020 · 39 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- R. Jacob VogelsteinDirector
- Terese BakerExecutive Officer
- Robert KlineDirector
- Thomas BrooksDirector
- Offering amount
- $15M
- Amount sold
- $511K
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.9MraisedNov 2019 · 15 investors · Other TechnologyRule 506(b)
▶$5.9MraisedNov 2019 · 15 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David FischellExecutive Officer, Director
- R. Jacob VogelsteinDirector
- Jeffrey MathiesenDirector
- Sherrie PerkinsDirector
- Eileen O'RourkeDirector
- Thomas BrooksDirector
- David OrosDirector
- Offering amount
- $6.3M
- Amount sold
- $5.9M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$200KraisedMar 2019 · 2 investors · Other TechnologyRule 506(b)
▶$200KraisedMar 2019 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eileen O'RourkeDirector
- David FischellExecutive Officer, Director
- Sherrie PerkinsDirector
- Thomas BrooksDirector
- R. Jacob VogelsteinDirector
- David OrosDirector
- Jeffrey MathiesenDirector
- David RosenExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $200K
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedMar 2019 · 1 investors · Other TechnologyRule 506(b)
▶$15MraisedMar 2019 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eileen O'RourkeDirector
- Thomas BrooksDirector
- Sherrie PerkinsDirector
- R. Jacob VogelsteinDirector
- Jeffrey MathiesenDirector
- David FischellExecutive Officer, Director
- David OrosDirector
- David RosenExecutive Officer, Director
- Offering amount
- $15M
- Amount sold
- $15M
- Proceeds to insiders
- $500K
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.5MraisedNov 2018 · 40 investors · Other TechnologyRule 506(b)
▶$13.5MraisedNov 2018 · 40 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David RosenExecutive Officer, Director
- David FischellExecutive Officer, Director
- Eileen O'RourkeDirector
- William KirwanDirector
- Terry LiermanDirector
- Phillip TorrenceExecutive Officer
- Offering amount
- $17M
- Amount sold
- $13.5M
- Minimum investment
- $10K
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.3MraisedJul 2017 · 8 investors · Other TechnologyRule 506(b)
▶$3.3MraisedJul 2017 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Terry LiermanDirector
- William KirwanDirector
- David FischellExecutive Officer, Director
- Eileen O'RourkeDirector
- David RosenExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $3.3M
- Minimum investment
- $10K
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$6.4MraisedMar 2016 · 70 investors · Other TechnologyRule 506(b)
▶$6.4MraisedMar 2016 · 70 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Michael FinneganDirector
- David FischellExecutive Officer, Director
- Terry LiermanDirector
- Eileen O'RourkeDirector
- William KirwanDirector
- David RosenExecutive Officer, Director
- Offering amount
- $31.1M
- Amount sold
- $6.4M
- Minimum investment
- $10K
- First sale
- Aug 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
▶$1.7MraisedFeb 2014 · 15 investors · Other TechnologyRule 506(b)
▶$1.7MraisedFeb 2014 · 15 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- David FischellExecutive Officer, Director
- David RosenExecutive Officer, Director
- Eileen O'RourkeDirector
- William KirwanDirector
- Robert FischellExecutive Officer, Director
- Terry LiermanDirector
- Offering amount
- $2.5M
- Amount sold
- $1.7M
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Neuralieve do?
- eNeura develops single-pulse transcranial magnetic stimulation (sTMS) neuromodulation devices for the acute and preventive treatment of migraine. Its products are used by patients, including veterans through the VA, and prescribed by healthcare providers, with operations in the US and UK.
- Who founded Neuralieve?
- Neuralieve was founded by Robert Fischell in 2012.
- Who are Neuralieve's investors?
- Neuralieve's investors include New Enterprise Associates (NEA).
- How much funding has Neuralieve raised?
- Neuralieve has disclosed $48.6M raised across 9 rounds.
- Where is Neuralieve headquartered?
- Neuralieve is headquartered in Sunnyvale, US.